Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sabit Delic
Observed names:
S. Delic,
Sabit Delić
Institution:
Munich Leukemia Laboratory (Germany)
Observed institutions:
Helmholtz Munich,
University Hospital Regensburg,
Munich Leukemia Laboratory (Germany),
Heinrich Heine University Düsseldorf,
Technical University of Munich
OpenAlex ID:
A5037726495
Application of an NGS ‐based 28‐gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera
2016
·
Sabit Delic
, Dominic Rose
, et al.
·
British Journal of Haematology
·
93
SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation
2011
·
Carina Lindemann
, Oliver Hackmann
, et al.
·
Acta Neuropathologica
·
93
MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation
2013
·
Sabit Delic
, Nadine Lottmann
, et al.
·
Neuro-Oncology
·
92
PDF
Identification and functional validation of CDH11, PCSK6 and SH3GL3 as novel glioma invasion‐associated candidate genes
2012
·
S. Delic
, N. Lottmann
, et al.
·
Neuropathology and Applied Neurobiology
·
57
Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM 1 and CMTM 3 as priority targets
2015
·
Sabit Delic
, Andreas Thuy
, et al.
·
Genes Chromosomes and Cancer
·
44
Generation of shRNA Transgenic Mice
2009
·
Christiane Hitz
, Patricia Steuber-Buchberger
, et al.
·
Methods in molecular biology
·
38
Genetic mouse models for behavioral analysis through transgenic RNAi technology
2008
·
S. Delic
, S. Streif
, et al.
·
Genes Brain & Behavior
·
27
PDF
FGF/FGFR2 Signaling Regulates the Generation and Correct Positioning of Bergmann Glia Cells in the Developing Mouse Cerebellum
2014
·
Florian Meier
, Florian Giesert
, et al.
·
PLoS ONE
·
23
Frequent Epigenetic Inactivation of DIRAS-1 and DIRAS-2 Contributes to Chemo-Resistance in Gliomas
2021
·
Tanja Rothhammer-Hampl
, Franziska Liesenberg
, et al.
·
Cancers
·
11
PDF
IDH1 - and IDH2 -mutated myeloid neoplasms: mutational pattern, clonal hierarchy, and the role in AML transformation
2026
·
Sandra Huber
, Flora Goessweiner
, et al.
·
Blood Advances
·
3
Additional genetic targets are present in the majority of AML patients with NPM1, KMT2A or NUP98 aberrations potentially impacting combination therapy with menin inhibitors
2025
·
Rainer Ordemann
, Sandra Huber
, et al.
·
Blood
·
1
PDF
Incidential Findings of Mutations in the PIGA Gene Are Highly Specific for the Presence of PNH Clones
2021
·
Gregor Hoermann
, Niroshan Nadarajah
, et al.
·
Blood
·
1
Frequent FLT3 and IDH co-mutations in acute myeloid leukemia with mutated NPM1, NUP98 rearrangement, and KMT2A partial tandem duplication but not rearrangement: potential for combined targeted therapy
2026
·
Rainer Ordemann
, Sandra Huber
, et al.
·
Haematologica
PDF
TP53 in Acute Myeloid Leukemia: Evolving from Just Another Prognostic Marker to an Actionable Biomarker Informing Treatment
2020
·
Peter Riccelli
, Marieke Hoefsmit
, et al.
·
Blood
Cdx Report Program: Heterogeneity Revealed in Current Reporting Practices for Hemato-Oncology Companion Diagnostic (CDx) Markers in Multiple Countries
2019
·
Sabit Delic
, Piers Blombery
, et al.
·
Blood
Venture Capital in Germany and the United Kingdom: A Focus on the Life Sciences Industry
2017
·
Aurelio Vincenti
, Sabit Delić
·
Journal of Business and Policy Research
The role of FGFR2 in cerebellum development and depressive disorders
2008
·
Sabit Delic
Show more works
View as search
Works count:
17
Citation count:
483
H-index:
9
I10-index:
9
Year
Topic
Type